ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Astria Therapeutics Inc

Astria Therapeutics Inc (ATXS)

8.96
-0.19
( -2.08% )
Updated: 12:22:57

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
8.96
Bid
8.93
Ask
9.00
Volume
70,133
8.7589 Day's Range 9.1353
6.58 52 Week Range 16.90
Market Cap
Previous Close
9.15
Open
9.10
Last Trade
12
@
8.96
Last Trade Time
12:23:02
Financial Volume
$ 627,261
VWAP
8.9439
Average Volume (3m)
286,264
Shares Outstanding
56,434,219
Dividend Yield
-
PE Ratio
-6.61
Earnings Per Share (EPS)
-1.29
Revenue
-
Net Profit
-72.89M

About Astria Therapeutics Inc

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Astria Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXS. The last closing price for Astria Therapeutics was $9.15. Over the last year, Astria Therapeutics shares have traded in a share price range of $ 6.58 to $ 16.90.

Astria Therapeutics currently has 56,434,219 shares outstanding. The market capitalization of Astria Therapeutics is $516.37 million. Astria Therapeutics has a price to earnings ratio (PE ratio) of -6.61.

ATXS Latest News

Astria Therapeutics Announces Positive Final Results from Target Enrollment in the ALPHA-STAR Phase 1b/2 Trial of Navenibart for HAE

-- Navenibart Demonstrated 6 Months of HAE Attack Prevention with 1 or 2 Doses -- -- 90-95% Mean Monthly Attack Rate Reduction Supporting Chronic Dosing 2 or 4 Times Per Year -- -- 67...

Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 32,500...

Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

-- Navenibart (STAR-0215), the Potential Market-Leading Therapy for the Treatment of Hereditary Angioedema, on Track for Expected Phase 3 Initiation in Q1 2025 -- -- Final 3- and 6-Month Results...

Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference

Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.59-6.17801047129.559.638.75893417969.4423364CS
4-1.58-14.99051233410.5411.018.75893979859.78074516CS
12-2.89-24.38818565411.8512.5158.6128626410.37831483CS
26-0.22-2.396514161229.1812.928.6133826010.85994204CS
521.4118.67549668877.5516.96.5858440011.5836474CS
1563.7270.99236641225.2416.92.3631667610.46971715CS
2600.435.041031652998.5316.92.3629270410.41139675CS

ATXS - Frequently Asked Questions (FAQ)

What is the current Astria Therapeutics share price?
The current share price of Astria Therapeutics is $ 8.96
How many Astria Therapeutics shares are in issue?
Astria Therapeutics has 56,434,219 shares in issue
What is the market cap of Astria Therapeutics?
The market capitalisation of Astria Therapeutics is USD 516.37M
What is the 1 year trading range for Astria Therapeutics share price?
Astria Therapeutics has traded in the range of $ 6.58 to $ 16.90 during the past year
What is the PE ratio of Astria Therapeutics?
The price to earnings ratio of Astria Therapeutics is -6.61
What is the reporting currency for Astria Therapeutics?
Astria Therapeutics reports financial results in USD
What is the latest annual profit for Astria Therapeutics?
The latest annual profit of Astria Therapeutics is USD -72.89M
What is the registered address of Astria Therapeutics?
The registered address for Astria Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Astria Therapeutics website address?
The website address for Astria Therapeutics is www.astriatx.com
Which industry sector does Astria Therapeutics operate in?
Astria Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXUNXU Inc
$ 1.6699
(586.07%)
421.64M
WATTEnergous Corporation
$ 1.461
(255.30%)
164.41M
INTZIntrusion Inc
$ 5.53
(156.02%)
114.5M
HOLOMicroCloud Hologram Inc
$ 4.52
(88.33%)
99.55M
CYNCYNGN Inc
$ 1.1699
(86.32%)
60.74M
ABPAbpro Holdings Inc
$ 2.0501
(-54.34%)
1.39M
TRAWTraws Pharma Inc
$ 7.825
(-41.69%)
896.28k
LITMSnow Lake Resources Ltd
$ 1.1168
(-30.20%)
44.58M
LGHLWLion Group Holding Ltd
$ 0.0052
(-25.71%)
54.82k
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
$ 66.74
(-24.56%)
8.96k
NXUNXU Inc
$ 1.6699
(586.07%)
421.64M
VINCVincerx Inc
$ 0.3519
(81.39%)
296.96M
XTIAXTI Aerospace Inc
$ 0.0398
(0.76%)
184.49M
WATTEnergous Corporation
$ 1.461
(255.30%)
164.41M
SMXSMX Security Matters Public Company
$ 0.58
(64.03%)
132.06M

Your Recent History

Delayed Upgrade Clock